Ozturk Demirdere

Responsible for Global Biopharmaceuticals P&L and deputize CFO as needed. Lead Financial Planning and Analysis for the Global Business Unit including, investor relations , target and latest forecasts as well as five-year Strategic Planning. Lead financial aspects of Business Development and Licensing (BD&L) activities, acting as key deal team member.

Lead Financial Planning and Analysis for the Business Unit including target and latest forecasts as well as five-year Strategic Planning. Finance Business Partner for Head of Commercial, International Markets supporting resource allocation, monthly financial tracking, and annual target setting. Lead financial aspects of Business Development and Licensing activities, acting as key deal team member; responsibilities include business cases preparation, financial assessments as well as contract negotiations.

Finance Manager supporting Business Development and Licensing team in authorized generics, in/out-licensing, profit share, and divestment deals. Performed financial profitability analysis including Net Present Value analysis for potential deals as well as prepared presentations to senior management. Served as Finance Business Partner to a development organization; manage overall month-end close activities, perform variance analysis, provide monthly forecasts

Managed financial planning and analysis for Oncology Global Development and Global Medical Affairs; overall budget of ~+$1B. Created planning cycle presentation for senior management. Served as Finance Business Partner for several functions, including Integrated Medical Safety, Biostatistics and Data Management, including budget preparation, spending management and analysis. Presented financial performance in function leadership meetings as a member of function leadership team.

Performed month-end closing activities including processing of accrual, reconciliation and posting of transactions, and checking bookings. Prepared globally and locally distributed financial. Responsible for consolidation of monthly financials and monthly variance analysis as well as monthly Rolling Forecast process; consolidation of data, data input to the system, variance and Risk&Opps analysis.

Prepared business plans, valuation and feasibility analysis, sector presentation, company teasers, and Information Memorandums. Coordinated consortium and co-lead IPO of Sinpas REIT (largest REIT offering in Turkey $384MM). Created one pagers and marketing documents for Reysas Logistics ($51MM), Selcuk Ecza ($181MM), Coke Bottling ($313MM), and Turkish Airlines ($208MM) IPOs. Prepared Information Memorandum and teaser for sale of Ankara Insurance and Pension Fund